Notably, an innovative aspect of our study is the application of lipidomic analysis to assess changes in the lipid composition of Hepa-RG cell membranes, particularly focusing on the modulation of SCD1 activity after HE treatment. The gene discussed is SCD; the disease is hereditary elliptocytosis.